{"id":"astemizole","rwe":[{"pmid":"41623588","year":"2026","title":"Advancing Torsades de pointes risk prediction: unveiling the role of drug metabolites through molecular docking.","finding":"","journal":"Toxicology research","studyType":"Clinical Study"},{"pmid":"41482941","year":"2026","title":"Novel cytochrome P450 2J isoforms in tree shrews are functional drug-metabolising enzymes involved in ebastine and astemizole oxidation.","finding":"","journal":"Xenobiotica; the fate of foreign compounds in biological systems","studyType":"Clinical Study"},{"pmid":"41423856","year":"2025","title":"Reassessing the Conduct of Patch Clamp Cardiac Ion Channel Assays to Improve Nonclinical Data Translation to Clinical ECG Changes and Proarrythmia Risk.","finding":"","journal":"Clinical and translational science","studyType":"Clinical Study"},{"pmid":"41027245","year":"2025","title":"Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8.","finding":"","journal":"Drug metabolism and pharmacokinetics","studyType":"Clinical Study"},{"pmid":"40313834","year":"2025","title":"Cancer Cell Identification via Lysosomal Membrane Microviscosities Using a Green-Emitting BODIPY Molecular Rotor.","finding":"","journal":"JACS Au","studyType":"Clinical Study"}],"tags":[{"label":"High Risk QT Prolonging Agents","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Potassium voltage-gated channel subfamily H member 2","category":"target"},{"label":"KCNH2","category":"gene"},{"label":"HRH1","category":"gene"},{"label":"HTR2A","category":"gene"},{"label":"R06AX11","category":"atc"},{"label":"Active","category":"status"},{"label":"Allergic conjunctivitis","category":"indication"},{"label":"Allergic rhinitis","category":"indication"},{"label":"Chronic idiopathic urticaria","category":"indication"},{"label":"Sneezing","category":"indication"},{"label":"Approved 1980s","category":"decade"},{"label":"Anti-Allergic Agents","category":"pharmacology"},{"label":"Histamine Agents","category":"pharmacology"},{"label":"Histamine Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists, Non-Sedating","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/high-risk-qt-prolonging-agents","drug":"High Risk QT Prolonging Agents","action":"Avoid combination","effect":"Highest Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of other Highest Risk QTc-Prolonging Agents","source":"DrugCentral","drugSlug":"high-risk-qt-prolonging-agents"},{"url":"/drug/azithromycin","drug":"azithromycin","action":"Avoid combination","effect":"May interact with Azithromycin","source":"DrugCentral","drugSlug":"azithromycin"},{"url":"/drug/cisapride","drug":"cisapride","action":"Avoid combination","effect":"May interact with Cisapride","source":"DrugCentral","drugSlug":"cisapride"},{"url":"/drug/clarithromycin","drug":"clarithromycin","action":"Avoid combination","effect":"May interact with Clarithromycin","source":"DrugCentral","drugSlug":"clarithromycin"},{"url":"/drug/crizotinib","drug":"crizotinib","action":"Monitor closely","effect":"May interact with Crizotinib","source":"DrugCentral","drugSlug":"crizotinib"},{"url":"/drug/darunavir","drug":"darunavir","action":"Avoid combination","effect":"May interact with Darunavir","source":"DrugCentral","drugSlug":"darunavir"},{"url":"/drug/efavirenz","drug":"efavirenz","action":"Avoid combination","effect":"May interact with Efavirenz","source":"DrugCentral","drugSlug":"efavirenz"},{"url":"/drug/erythromycin","drug":"erythromycin","action":"Avoid combination","effect":"May interact with Erythromycin","source":"DrugCentral","drugSlug":"erythromycin"},{"url":"/drug/fluvoxamine","drug":"fluvoxamine","action":"Avoid combination","effect":"May interact with Fluvoxamine Maleate","source":"DrugCentral","drugSlug":"fluvoxamine"},{"url":"/drug/indinavir","drug":"indinavir","action":"Avoid combination","effect":"May interact with Indinavir Sulfate","source":"DrugCentral","drugSlug":"indinavir"},{"url":"/drug/itraconazole","drug":"itraconazole","action":"Avoid combination","effect":"May interact with Itraconazole","source":"DrugCentral","drugSlug":"itraconazole"},{"url":"/drug/ketoconazole","drug":"ketoconazole","action":"Avoid combination","effect":"May interact with Ketoconazole","source":"DrugCentral","drugSlug":"ketoconazole"},{"url":"/drug/mibefradil","drug":"mibefradil","action":"Avoid combination","effect":"May interact with Mibefradil Dihydrochloride","source":"DrugCentral","drugSlug":"mibefradil"},{"url":"/drug/nefazodone","drug":"nefazodone","action":"Avoid combination","effect":"May interact with Nefazodone","source":"DrugCentral","drugSlug":"nefazodone"},{"url":"/drug/oleandomycin","drug":"oleandomycin","action":"Avoid combination","effect":"May interact with Oleandomycin (As Troleandomycin)","source":"DrugCentral","drugSlug":"oleandomycin"},{"url":"/drug/quinine","drug":"quinine","action":"Avoid combination","effect":"May interact with Quinine","source":"DrugCentral","drugSlug":"quinine"},{"url":"/drug/ritonavir","drug":"ritonavir","action":"Avoid combination","effect":"May interact with Ritonavir","source":"DrugCentral","drugSlug":"ritonavir"},{"url":"/drug/sotalol","drug":"sotalol","action":"Monitor closely","effect":"May interact with Sotalol","source":"DrugCentral","drugSlug":"sotalol"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ASTEMIZOLE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:39:10.950598+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:39:17.184917+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ASTEMIZOLE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:39:17.575871+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Histamine H1 receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:39:18.732144+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL296419/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:39:18.383022+00:00"}},"allNames":"hismanal","offLabel":[],"synonyms":["R 43 512","astemizole","astemisan","hismanal","histazol"],"timeline":[{"date":"1988-12-31","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"brandName":"Hismanal","ecosystem":[{"indication":"Allergic conjunctivitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alcaftadine","slug":"alcaftadine","company":"Allergan"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Allergic rhinitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null},{"indication":"Chronic idiopathic urticaria","otherDrugs":[{"name":"cetirizine","slug":"cetirizine","company":"J And J Consumer Inc"},{"name":"desloratadine","slug":"desloratadine","company":"Merck Sharp Dohme"},{"name":"fexofenadine","slug":"fexofenadine","company":"Sanofi Aventis Us"},{"name":"levocetirizine","slug":"levocetirizine","company":"Ucb Inc"}],"globalPrevalence":68000000},{"indication":"Sneezing","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Potassium voltage-gated channel subfamily H member 2","novelty":"Follow-on","targets":[{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"},{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor"},{"gene":"HTR2A","source":"DrugCentral","target":"5-hydroxytryptamine receptor 2A","protein":"5-hydroxytryptamine receptor 2A"},{"gene":"HTR2B","source":"DrugCentral","target":"5-hydroxytryptamine receptor 2B","protein":"5-hydroxytryptamine receptor 2B"},{"gene":"ADRA1D","source":"DrugCentral","target":"Alpha-1D adrenergic receptor","protein":"Alpha-1D adrenergic receptor"},{"gene":"HTR2C","source":"DrugCentral","target":"5-hydroxytryptamine receptor 2C","protein":"5-hydroxytryptamine receptor 2C"},{"gene":"TMEM97","source":"DrugCentral","target":"Transmembrane protein 97","protein":"Transmembrane protein 97"},{"gene":"HTR3A","source":"DrugCentral","target":"5-hydroxytryptamine receptor 3A","protein":"5-hydroxytryptamine receptor 3A"},{"gene":"DRD3","source":"DrugCentral","target":"D(3) dopamine receptor","protein":"D(3) dopamine receptor"},{"gene":"CHRM3","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M3","protein":"Muscarinic acetylcholine receptor M3"}],"modality":"Small Molecule","drugClass":"High Risk QT Prolonging Agents","explanation":"","oneSentence":"","technicalDetail":"Hismanal acts as a selective blocker of the hERG potassium channel (KCNH2), which is involved in the repolarization phase of the cardiac action potential, and also has a role in the regulation of mast cell degranulation and histamine release."},"commercial":{"launchDate":"1988","_launchSource":"DrugCentral (FDA 1988-12-31, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/249","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ASTEMIZOLE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:50:20.572905","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:39:19.994083+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cyproheptadine","drugSlug":"cyproheptadine","fdaApproval":"1961-10-17","genericCount":31,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"antazoline","drugSlug":"antazoline","fdaApproval":"1990-04-30","relationship":"same-class"},{"drugName":"triprolidine","drugSlug":"triprolidine","fdaApproval":"1983-05-17","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"azatadine","drugSlug":"azatadine","fdaApproval":"1977-03-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"terfenadine","drugSlug":"terfenadine","fdaApproval":"","relationship":"same-class"},{"drugName":"loratadine","drugSlug":"loratadine","fdaApproval":"1993-04-12","genericCount":29,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ketotifen","drugSlug":"ketotifen","fdaApproval":"1999-07-02","patentExpiry":"Mar 27, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"acrivastine","drugSlug":"acrivastine","fdaApproval":"1994-03-25","relationship":"same-class"},{"drugName":"azelastine","drugSlug":"azelastine","fdaApproval":"1996-11-01","patentExpiry":"Jun 4, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"epinastine","drugSlug":"epinastine","fdaApproval":"2003-10-16","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fexofenadine","drugSlug":"fexofenadine","fdaApproval":"1996-07-25","patentExpiry":"Aug 2, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"desloratadine","drugSlug":"desloratadine","fdaApproval":"2001-12-21","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"astemizole","indications":{"approved":[{"name":"Allergic conjunctivitis","source":"DrugCentral","snomedId":473460002,"regulator":"FDA"},{"name":"Allergic rhinitis","source":"DrugCentral","snomedId":61582004,"regulator":"FDA"},{"name":"Chronic idiopathic urticaria","source":"DrugCentral","snomedId":302162004,"regulator":"FDA","usPrevalence":null,"globalPrevalence":68000000,"prevalenceMethod":"curated","prevalenceSource":"Allergy, 2020 (PMID:31494963)"},{"name":"Sneezing","source":"DrugCentral","snomedId":76067001,"regulator":"FDA"}],"offLabel":[{"name":"Urticaria","source":"DrugCentral","drugName":"ASTEMIZOLE","evidenceCount":81,"evidenceLevel":"strong"}],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"cyproheptadine","brandName":"cyproheptadine","genericName":"cyproheptadine","approvalYear":"1961","relationship":"same-class"},{"drugId":"antazoline","brandName":"antazoline","genericName":"antazoline","approvalYear":"1990","relationship":"same-class"},{"drugId":"triprolidine","brandName":"triprolidine","genericName":"triprolidine","approvalYear":"1983","relationship":"same-class"},{"drugId":"azatadine","brandName":"azatadine","genericName":"azatadine","approvalYear":"1977","relationship":"same-class"},{"drugId":"terfenadine","brandName":"terfenadine","genericName":"terfenadine","approvalYear":"","relationship":"same-class"},{"drugId":"loratadine","brandName":"loratadine","genericName":"loratadine","approvalYear":"1993","relationship":"same-class"},{"drugId":"ketotifen","brandName":"ketotifen","genericName":"ketotifen","approvalYear":"1999","relationship":"same-class"},{"drugId":"acrivastine","brandName":"acrivastine","genericName":"acrivastine","approvalYear":"1994","relationship":"same-class"},{"drugId":"azelastine","brandName":"azelastine","genericName":"azelastine","approvalYear":"1996","relationship":"same-class"},{"drugId":"epinastine","brandName":"epinastine","genericName":"epinastine","approvalYear":"2003","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000147536","MMSL":"4224","NDDF":"003413","UNII":"7HU6337315","VUID":"4019379","CHEBI":"CHEBI:2896","VANDF":"4019379","INN_ID":"4755","RXNORM":"202818","UMLSCUI":"C0085170","chemblId":"CHEMBL296419","ChEMBL_ID":"CHEMBL296419","KEGG_DRUG":"D00234","DRUGBANK_ID":"DB00637","PDB_CHEM_ID":"XB7","PUBCHEM_CID":"2247","SNOMEDCT_US":"387333002","IUPHAR_LIGAND_ID":"2603","MESH_DESCRIPTOR_UI":"D016589"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"2%"},"publicationCount":786,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"R06AX11","allCodes":["R06AX11"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Feb","pmid":"41623588","title":"Advancing Torsades de pointes risk prediction: unveiling the role of drug metabolites through molecular docking.","journal":"Toxicology research"},{"date":"2026 Jan","pmid":"41482941","title":"Novel cytochrome P450 2J isoforms in tree shrews are functional drug-metabolising enzymes involved in ebastine and astemizole oxidation.","journal":"Xenobiotica; the fate of foreign compounds in biological systems"},{"date":"2025 Dec","pmid":"41423856","title":"Reassessing the Conduct of Patch Clamp Cardiac Ion Channel Assays to Improve Nonclinical Data Translation to Clinical ECG Changes and Proarrythmia Risk.","journal":"Clinical and translational science"},{"date":"2025 Dec","pmid":"41027245","title":"Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8.","journal":"Drug metabolism and pharmacokinetics"},{"date":"2025 Apr 28","pmid":"40313834","title":"Cancer Cell Identification via Lysosomal Membrane Microviscosities Using a Green-Emitting BODIPY Molecular Rotor.","journal":"JACS Au"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1988","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:39:19.994083+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}